Kirkland Suffers Swift Defeat in Teva FDA Fight

Less than a week after Teva Pharmaceutical Industries sued the FDA to block competitors from marketing generic versions of its blockbuster multiple sclerosis drug Copaxone, the company's lawyers are back where they started.

YOUR COMPLIMENTARY 15-DAY LAW.COM TRIAL HAS ENDED.
Subscribe now to continue reading →

To continue reading, upgrade and become a Law.com subscriber.
Get 2 MONTHS FREE when you sign up for a 12 month subscription.